Growth N. V. Biotech, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 7,368,584 shares at $2.09 ($15.2M) on 2025-03-19, disclosed to the SEC on 2025-03-20.
Open-market sale of $15.2M BDTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.94 | 300,000 | $582K | 3.8% |
| 2 | $1.95 | 584,292 | $1.1M | 7.5% |
| 3 | $1.95 | 584,292 | $1.1M | 7.5% |
| 4 | $2.00 | 2,000,000 | $4.0M | 26.3% |
| 5 | $2.07 | 1,000,000 | $2.1M | 13.6% |
| 6 | $2.07 | 1,000,000 |
| $2.1M |
| 13.6% |
| 7 | $2.09 | 400,000 | $836K | 5.5% |
| 8 | $2.12 | 500,000 | $1.1M | 7.0% |
| 9 | $2.31 | 1,000,000 | $2.3M | 15.2% |
| Total | $2.06 avg | 7,368,584 | $15.2M | 100% |
| Filing → |
| BDTX | BUY | 2022-11-02 | $449K | — | Filing → |
| EPIX | BUY | 2022-10-28 | $8.2M | — | Filing → |
| EPIX | BUY | 2022-07-18 | $3.5M | — | Filing → |